Rebalix
Logo JPMorganJPMorgan · sheet of 10 September 2026
ETF sheet · official issuer and register data

Global ex US Research Enhanced Index Equity Active UCITS ETF

JXUS · IE0006FBEDB6 · class JPM - USD (acc) · USD · domicile Ireland
Equity · GlobalactiveSFDR art. 8
Comparison benchmark: M1WOU
TER
0.25%+ trans. 0.06%
Fund size
9 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Gestione attiva (dal KID)active management
Income
Accumulating
Launch 16 Jun 2026 · costs from the KID as of 2 Sept 2026 · 282 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The objective of the Sub-Fund is to achieve a longterm return in excess of the Benchmark by actively investing primarily in a portfolio of companies, globally, excluding the United States of America ("US"). Investment Policy: The Sub-Fund pursues an actively-managed investment strategy. The Sub-Fund aims to invest at least 67% of its assets (excluding assets held for ancillary liquidity purposes) in equity securities of companies, globally, excluding issuers that are domiciled in, or carry out the main part of their activity in…

Performance since series start (in euro) — base 100

16 Jun 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
105100103
High 105 (13 Aug 2026) · low 100 (26 Jun 2026) · last 103. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+2.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JXUS · IE0006FBEDB61
RebalixJXUS · IE0006FBEDB6 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 282 securities · top-10 weight = 14.6%
Top holdingsWeight
ASML HOLDING NV /EUR/3.1%
SIEMENS AG-REG /EUR/1.5%
ASTRAZENECA PLC /GBP/1.4%
ALLIANZ SE REGISTERED /EUR/1.4%
HSBC HOLDINGS PLC /GBP/1.3%
BANCO SANTANDER SA /EUR/1.3%
UNICREDIT SPA /EUR/1.2%
BHP GROUP LTD /AUD/1.2%
ROCHE HOLDING AG /CHF/1.1%
NESTLE SA-REG /CHF/1.1%
Countries (% of fund)
Japan21.3%United Kingdom13.6%Canada12.3%France9.9%Germany9.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
JXUS · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE0006F
Factsheet · jp.techrules.com/rebrandingPDF/LoadPdf.aspx?ShareClassId=16108&country
Prospectus · wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE0006F
The live sheet, always up to date
rebalix.com/en/etf/IE0006FBEDB6
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · JXUS · IE0006FBEDB62